BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25640271)

  • 1. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
    Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
    Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors.
    Ishikawa T; Takahashi K; Ikeda N; Kajimoto Y; Hagiya Y; Ogura S; Miyatake S; Kuroiwa T
    Pharmaceutics; 2011 Sep; 3(3):615-35. PubMed ID: 24310600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
    Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
    Barron GA; Moseley H; Woods JA
    J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
    Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
    J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
    Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
    J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
    Robey RW; Steadman K; Polgar O; Bates SE
    Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
    Bebes A; Nagy T; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    J Photochem Photobiol B; 2011 Nov; 105(2):162-6. PubMed ID: 21911299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.
    Sun W; Kajimoto Y; Inoue H; Miyatake S; Ishikawa T; Kuroiwa T
    Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):42-50. PubMed ID: 23465372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z; Gibson SL; Foster TH; Hilf R
    Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
    Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
    BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.
    Kawai N; Hirohashi Y; Ebihara Y; Saito T; Murai A; Saito T; Shirosaki T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Shichinohe T; Li L; Hirano S; Torigoe T
    PLoS One; 2019; 14(5):e0216503. PubMed ID: 31083682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.